China type 2 diabetes treatment status survey of treatment pattern of oral drugs users (Q45873637)

17 December 2017

title

China type 2 diabetes treatment status survey of treatment pattern of oral drugs users (English)

1 reference

17 December 2017

1 reference

Linong Ji

1

1 reference

17 December 2017

Juming Lu

2

1 reference

17 December 2017

Jianping Weng

3

1 reference

17 December 2017

Weiping Jia

4

1 reference

17 December 2017

Haoming Tian

5

1 reference

17 December 2017

Dalong Zhu

6

1 reference

17 December 2017

Xiaoping Xing

7

1 reference

17 December 2017

Lixin Guo

8

1 reference

17 December 2017

publication date

7 August 2014

1 reference

17 December 2017

published in

Journal of diabetes

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

166-173

1 reference

17 December 2017

Prevalence of diabetes among men and women in China

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Medical care and payment for diabetes in China: enormous threat and great opportunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

21 January 2018

Oral Antidiabetic Agents

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Insulinotropic meglitinide analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Targeting Postprandial Hyperglycemia: A Comparative Study of Insulinotropic Agents in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Incidence and predictors of hypoglycaemia in type 2 diabetes - an analysis of the prospective DiaRegis registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Changing the treatment paradigm for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12165

21 January 2018

Identifiers

DOI

10.1111/1753-0407.12165

1 reference

17 December 2017

PubMed ID

24809622

1 reference

17 December 2017